Ohio State University Comprehensive Cancer Center at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

Ohio State University Comprehensive Cancer Center brings 4 presentations to ISLB 2026 in Madrid. Its work centres on the clinical role of circulating tumour DNA in solid tumours. One focus is what it would take for blood tumour DNA results to drive first-line treatment decisions rather than only complement other tests.

OrganizationISLB 2026 Attendance
cancer.osu.edu
Hospitals & cancer centres
NCI-designated comprehensive cancer center of Ohio State University in Columbus, including its dedicated cancer hospital.
Industry
Sat Nov 7
12:30pm–1:30pm
Part of Beyond Complementarity: Moving to Frontline ctDNA Decision-making in Solid Tumors
Chair Welcome and Framing
Industry hosted by MSD
Clinical use · ctDNA & MRD
Industry
Sat Nov 7
12:30pm–1:30pm
Industry
Sat Nov 7
12:30pm–1:30pm
Industry
Sat Nov 7
12:30pm–1:30pm
Part of Beyond Complementarity: Moving to Frontline ctDNA Decision-making in Solid Tumors
Closing
Industry hosted by MSD
Clinical use · ctDNA & MRD
Session
Sat Nov 7
1:45pm–3:15pm
Stakeholder Workshop
Session
Sat Nov 7
4:00pm–5:30pm
Molecular Tumor Board
Clinical use

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Ohio State University Comprehensive Cancer Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction